Relative Strength Chart Vertex Pharmaceuticals Incorporated

Stocks

Market Closed - Nasdaq 00:00:00 04/09/2026 +04			5-day change	1st Jan Change
557.96 ^USD	+0.22%		+1.90%	+23.07%

09-02	Evercore ISI Adjusts Vertex Pharmaceuticals Price Target to $600 From $535, Maintains Outperform Rating	MT
09-02	Vertex Pharmaceuticals Incorporated Announces Chief Financial Officer Changes, Effective January 1, 2027	CI

End-of-day quotes

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	VERTEX PHARMACEUTICALS INCORPORATED	Other Pharmaceuticals	+0.22%	+1.90%	+23.07%	+40.68%	+181.73%	141B